Presidio Partners


Presidio Partners is a venture capital firm that redefines venture investing and management by focusing on active portfolio management, transparency, teamwork, and accountability. With over 25 years of experience, the firm leverages its deep sector knowledge in life sciences, information technology, and energy technology to identify and maximize opportunities. Presidio Partners emphasizes a fresh approach to venture capital, driven by experience and a commitment to creating significant companies that can become game changers. The firm values transparency and collaboration, assigning two team members to every major investment to stimulate collaboration and accountability.

Presidio Partners

Presidio Partners

2181 Greenwich Street, San Francisco, CA 94123


Portfolio

Investments to secure and support U.S based drug supply and manufacturing.

#Life Sciences

Unveiled a world-class executive team.

#Energy Technology

Completed first development milestone toward a single-dose intranasal COVID-19 vaccine.

#Life Sciences

Received FDA approval for IBSRELA® (tenapanor) for IBS-C.

#Life Sciences

Raised more than $20M Series C financing.

#Energy Technology

Completed $20.6 million financing to further advance its late-stage ADHD product pipeline.

#Life Sciences